Exondys Sales, Takeover Speculation Fuel Sarepta Therapeutics By: Benzinga via Benzinga April 28, 2017 at 11:31 AM EDT Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are up more than 6.5 percent Friday after the company reported first-quarter net revenue ... Read More >> Related Stocks: Sanofi-Aventis S.A. ADR Sarepta Therapeutics